Product

Cromoglycate

1 clinical trial

2 indications

Indication
Schizophrenia
Clinical trial
Cromoglicte Adjunctive Therapy for Outpatients With Schizophrenia
Status: Recruiting, Estimated PCD: 2024-08-01